These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7723913)

  • 21. Erythropoietin use in a Jehovah's Witness patient.
    Walton T; Macon EJ
    Ann Pharmacother; 2002 Apr; 36(4):729-30. PubMed ID: 11936087
    [No Abstract]   [Full Text] [Related]  

  • 22. Dose escalation induces tolerance to side-effects of erythropoietin in a patient with dialysis anaemia: case report.
    Ohira N; Takasugi K; Takasugi N; Yorioka N; Ito T; Kushihata S; Takemasa A
    J Int Med Res; 1998; 26(2):102-5. PubMed ID: 9602990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erythropoietin: from established therapeutic procedures in renal anemia to future areas of use].
    Marsen TA; Pollok M; Baldamus CA
    Med Klin (Munich); 1992 Apr; 87(4):207-14. PubMed ID: 1579099
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 25. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
    Marsden JT; Sherwood RA; Hillis A; Peters TJ
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
    [No Abstract]   [Full Text] [Related]  

  • 26. Understanding epoetin use: databases or clinical trials?
    Roger SD
    Nephrology (Carlton); 2007 Apr; 12(2):118-9. PubMed ID: 17371331
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of the good effect of low doses of erythropoietin].
    Shostka GD; Dobronravov VA; Vasil'ev AN
    Urol Nefrol (Mosk); 1991; (5):74-5. PubMed ID: 1755131
    [No Abstract]   [Full Text] [Related]  

  • 29. [Erythropoietin treatment in children with chronic renal failure].
    Ito K; Hattori M
    Nihon Rinsho; 1991 Dec; 49 Suppl():688-94. PubMed ID: 1808336
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
    Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
    Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythropoietin can be administered during dialysis. A kinetic analysis.
    Petersen J; Kang MS; Hays MT
    ASAIO J; 1996; 42(1):27-33. PubMed ID: 8808454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin and its use in renal failure.
    Sulková S; Krajhanzl A
    EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
    Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
    Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage.
    Port RE; Kiepe D; Van Guilder M; Jelliffe RW; Mehls O
    Clin Pharmacokinet; 2004; 43(1):57-70. PubMed ID: 14715051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 36. [Advances in therapy of renal anemia: darbepoetin alfa].
    Schaefer R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):955-7. PubMed ID: 12635460
    [No Abstract]   [Full Text] [Related]  

  • 37. Experience with low dose intravenous and subcutaneous administration of recombinant human erythropoietin.
    McMahon LP; Dawborn JK
    Am J Nephrol; 1990; 10(5):404-8. PubMed ID: 2080791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The advantages of intravenous renal anaemia treatment in an undernourished patient with chronic kidney disease.
    Shiell KA; McKane W; Wilkie M
    Curr Med Res Opin; 2003; 19(6):481-4. PubMed ID: 14594519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin therapy in patients with chronic renal failure.
    Pinevich AJ; Petersen J
    West J Med; 1992 Aug; 157(2):154-7. PubMed ID: 1441466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.